Clinical Laserthermia Systems AB (publ) (STO:CLS.B)

STO:CLS.B Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.2	22.51	15.33	10.45	1.71	0.6
Short-Term Investments	-	-	-	0.14	29.46	11.28
Cash & Short-Term Investments	16.2	22.51	15.33	10.59	31.17	11.87
Cash Growth	35.35%	46.80%	44.80%	-66.03%	162.53%	106.06%
Accounts Receivable	7.87	4.59	2.64	1.5	0.64	0.46
Other Receivables	1.82	2.18	2.14	8.89	5.81	2.9
Receivables	9.69	6.77	4.78	10.4	6.45	3.36
Inventory	7.79	8.15	6.12	3.07	4.61	5.61
Prepaid Expenses	0.71	0.98	0.92	0.2	0.2	0.06
Total Current Assets	34.4	38.41	27.15	24.26	42.43	20.9
Property, Plant & Equipment	3.62	13.14	3.88	1.8	1.48	2.05
Other Intangible Assets	5.1	2.56	5.83	2.48	2.28	2.24
Long-Term Accounts Receivable	-	-	-	0.12	0.08	0.2
Long-Term Deferred Tax Assets	12.43	13.53	7.82	5.66	3.04	-
Long-Term Deferred Charges	7.34	10.93	13.06	15.18	17.31	19.01
Other Long-Term Assets	9.21	-	-	-	0.12	-
Total Assets	72.1	78.56	57.73	49.51	66.74	44.4
Accounts Payable	2.8	6.3	9.17	5.93	4.31	4.46
Accrued Expenses	3.15	4.84	3.18	3.43	1.75	4.14
Short-Term Debt	-	-	-	30.68	35	-
Current Portion of Long-Term Debt	-	-	-	-	0.17	0.47
Current Portion of Leases	0.22	0.22	0.23	-	-	-
Current Income Taxes Payable	0.08	0.07	0.18	0.45	0.31	-
Other Current Liabilities	1.42	1.45	1.22	1.16	3.92	20.96
Total Current Liabilities	7.66	12.87	13.97	41.64	45.45	30.03
Long-Term Debt	-	-	-	-	0.1	0.2
Long-Term Leases	0.01	0.01	0.22	-	-	-
Other Long-Term Liabilities	-	-0	-	-	-	0.24
Total Liabilities	7.67	12.87	14.2	41.64	45.55	30.47
Common Stock	58.52	46.58	15.43	12.05	6.09	4.21
Additional Paid-In Capital	3.08	39.95	9.8	66.13	339.83	270.44
Retained Earnings	6.28	-17.77	19.63	-67.7	-323.83	-263.07
Comprehensive Income & Other	-0.65	-0.03	0.92	-1.26	-0.3	2.36
Total Common Equity	67.23	68.72	45.77	9.22	21.79	13.93
Minority Interest	-2.8	-3.04	-2.24	-1.35	-0.61	-
Shareholders' Equity	64.43	65.69	43.53	7.87	21.18	13.93
Total Liabilities & Equity	72.1	78.56	57.73	49.51	66.74	44.4
Total Debt	0.22	0.22	0.45	30.68	35.27	0.67
Net Cash (Debt)	15.98	22.28	14.88	-20.09	-4.11	11.2
Net Cash Growth	38.75%	49.78%	-	-	-	138.88%
Net Cash Per Share	0.84	2.02	4.43	-48.17	-14.29	50.71
Filing Date Shares Outstanding	25.67	20.17	6.68	0.65	0.33	0.23
Total Common Shares Outstanding	25.67	20.17	6.68	0.65	0.33	0.23
Working Capital	26.74	25.54	13.17	-17.38	-3.03	-9.13
Book Value Per Share	2.62	3.41	6.85	14.15	66.22	61.28
Tangible Book Value	62.12	66.16	39.94	6.74	19.52	11.69
Tangible Book Value Per Share	2.42	3.28	5.98	10.34	59.30	51.44
Machinery	-	6.67	5.04	4.25	4.21	4.06
Construction In Progress	-	8.36	-	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.